Department of Cancer Biology, The Kansas University Medical Center, Kansas City, KS, United States of America.
Stowers Institute for Medical Research, Kansas City, Missouri, United States of America.
PLoS One. 2021 Nov 17;16(11):e0259128. doi: 10.1371/journal.pone.0259128. eCollection 2021.
Breast Cancer Metastasis Suppressor 1 (BRMS1) expression is associated with longer patient survival in multiple cancer types. Understanding BRMS1 functionality will provide insights into both mechanism of action and will enhance potential therapeutic development. In this study, we confirmed that the C-terminus of BRMS1 is critical for metastasis suppression and hypothesized that critical protein interactions in this region would explain its function. Phosphorylation status at S237 regulates BRMS1 protein interactions related to a variety of biological processes, phenotypes [cell cycle (e.g., CDKN2A), DNA repair (e.g., BRCA1)], and metastasis [(e.g., TCF2 and POLE2)]. Presence of S237 also directly decreased MDA-MB-231 breast carcinoma migration in vitro and metastases in vivo. The results add significantly to our understanding of how BRMS1 interactions with Sin3/HDAC complexes regulate metastasis and expand insights into BRMS1's molecular role, as they demonstrate BRMS1 C-terminus involvement in distinct protein-protein interactions.
乳腺癌转移抑制因子 1(BRMS1)的表达与多种癌症类型患者的生存时间延长有关。了解 BRMS1 的功能将有助于深入了解其作用机制,并增强潜在的治疗开发。在这项研究中,我们证实 BRMS1 的 C 末端对于转移抑制至关重要,并假设该区域的关键蛋白相互作用将解释其功能。S237 位点的磷酸化状态调节与多种生物学过程、表型(如细胞周期[如 CDKN2A]、DNA 修复[如 BRCA1])和转移[如 TCF2 和 POLE2]相关的 BRMS1 蛋白相互作用。S237 的存在还直接降低了 MDA-MB-231 乳腺癌细胞系在体外的迁移和体内的转移。这些结果大大增加了我们对 BRMS1 与 Sin3/HDAC 复合物相互作用如何调节转移的理解,并扩展了对 BRMS1 分子作用的认识,因为它们表明 BRMS1 C 末端参与了不同的蛋白-蛋白相互作用。